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Snake	  venoms	  contain	  various	  constituents	  that	  may	  be	  useful	  for	  medicinal	  
purposes,	  and	  previous	  research	  has	  indicated	  that	  some	  snake	  venom	  components	  
inhibit	  cancer	  cell	  proliferation	  by	  both	  general	  and	  specific	  mechanisms.	  
Paradoxically,	  the	  creatures	  that	  many	  people	  fear	  may	  carry	  a	  possible	  treatment	  
for	  an	  equally	  feared	  disease,	  cancer.	  The	  purpose	  of	  this	  study	  is	  to	  evaluate	  the	  
effects	  of	  Ahaetulla	  snake	  venom	  and	  purified	  toxins	  on	  the	  proliferation	  of	  MCF-­‐7	  
breast	  cancer	  cells.	  Our	  working	  hypothesis	  is	  that	  crude	  venom,	  as	  well	  as	  purified	  
proteins	  proteins,	  will	  inhibit	  cancer	  cell	  growth	  but	  show	  minimal	  effects	  on	  
normal	  cells.	  Cells	  were	  cultured,	  subcultivated	  and	  then	  added	  to	  wells	  of	  a	  
microtiter	  plate	  containing	  varying	  concentrations	  of	  Ahaetulla	  venom.	  After	  24	  hr	  
incubation	  at	  37	  ºC,	  cell	  proliferation	  in	  the	  presence	  and	  absence	  of	  venom	  was	  
quantified	  (MTT	  assay).	  Initial	  results	  indicate	  that	  the	  venom	  contains	  potent	  anti-­‐
proliferative	  activities,	  an	  interesting	  observation	  in	  light	  of	  the	  fact	  that	  this	  
potency	  does	  not	  correlate	  with	  overall	  venom	  toxicity,	  which	  is	  very	  low	  for	  
mammals.	  This	  anti-­‐proliferative	  effect	  was	  found	  to	  be	  contained	  in	  one	  component	  
isolated	  by	  size	  exclusion	  fractionation	  of	  venom.	  We	  are	  currently	  purifying	  this	  
venom	  protein(s)	  with	  the	  goal	  of	  obtaining	  a	  purified	  component(s)	  which	  will	  
inhibit	  cancer	  cell	  proliferation	  but	  not	  affect	  normal	  cells.	  This	  research	  has	  the	  
potential	  to	  discover	  novel	  compounds	  with	  specific	  anti-­‐cancer	  properties,	  which	  
in	  turn	  can	  assist	  in	  rational	  drug	  design.	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